Chiti Chopra

Chiti Chopra has a diverse work experience in various financial roles in the biotechnology and pharmaceutical industry. Chiti began their career at Morgan Stanley in 2015, working in wealth management. Chiti then joined Depomed, Inc. in 2016 as a Financial Analyst and later became a Senior Financial Analyst. In 2018, they moved to MyoKardia as a Senior Financial Analyst and was later promoted to Manager of FP&A. In 2019, Chiti joined Rezolute, Inc. as a Senior Manager in FP&A and eventually became the Associate Director of Finance and Strategy. Chiti also held roles as the Director of Finance and Strategy and Director of Corporate Strategy. In 2023, Chiti joined Vir Biotechnology as a Director and then transitioned to Encoded Therapeutics Inc. as the Director of FP&A.

Chiti Chopra holds a Bachelor's degree in Economics (Cum Laude) with a minor in Business/Managerial Economics from the University of California, Davis.